Corrigendum to "Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects" [Bioorg. Med. Chem. Lett. 26 (2016) 5724-5728]

Bioorg Med Chem Lett. 2017 Mar 1;27(5):1333. doi: 10.1016/j.bmcl.2017.01.082. Epub 2017 Feb 4.

Authors

Matthew Lombardo¹, Kate Bender², Clare London², Michael A Plotkin², Melissa Kirkland², Joel Mane², Michele Pachanski², Wayne Geissler², John Cummings², Bahanu Habulihaz², Taro E Akiyama², Jerry Di Salvo², Maria Madeira², Joanna Pols², Mary Ann Powles², Michael F Finley², Eric Johnson², Thomas Roussel², Victor N Uebele², Alejandro Crespo², Dennis Leung², Candice Alleyne², Dorina Trusca², Ying Lei², Andrew D Howard², Feroze Ujjainwalla², James R Tata², Christopher J Sinz²

Affiliations

¹ Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: matthew_lombardo@merck.com.
² Merck & Co., Inc., Kenilworth, NJ, USA.

PMID: 28169160
DOI: 10.1016/j.bmcl.2017.01.082

No abstract available

Publication types

Published Erratum